INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹47 Cr | ₹114 Cr | ₹-430 Cr | ₹370 Cr | ₹16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDEGENE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹-430 Cr |
| Mar2022 | ₹370 Cr |
| Mar2021 | ₹16 Cr |
How is Net Cash Inflow / Outflow of INDEGENE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | -59.14 | |
| Mar2024 | ₹114 Cr | Positive | |
| Mar2023 | ₹-430 Cr | Negative | |
| Mar2022 | ₹370 Cr | 2,174.92 | |
| Mar2021 | ₹16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,653.5 Cr | 4% | 6.9% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 4% |
6.9% |
-11.9% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses